Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Viruses|November 17, 2018
Recent Advances in Zika Virus VaccinesHimanshu Garg, Tugba Mehmetoglu-Gurbuz, Anjali JoshiViruses|October 5, 2019
Differential Pathogenicity of SHIV KB9 and 89.6 Env Correlates with Bystander Apoptosis Induction in CD4+ T cellsTugba Mehmetoglu-Gurbuz, Anjali Joshi, Himanshu GargScientific Reports|March 6, 2020
Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika VirusHimanshu Garg, Tugba Mehmetoglu-Gurbuz, Anjali JoshiVirology Journal|January 31, 2021
Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockoutTugba Mehmetoglu-Gurbuz, Rose Yeh, Himanshu Garg, et al.Vaccine|October 15, 2019
Capsid containing virus like particle vaccine against Zika virus made from a stable cell lineHimanshu Garg, Tugba Mehmetoglu-Gurbuz, Gregory M Ruddy, et al.Transportation Research Record|April 11, 2024
Transportation as a Disease Vector in COVID-19: Border Mobility and Disease SpreadOkan Gurbuz, Rafael M Aldrete, David Salgado, et al.BMC Infectious Diseases|January 18, 2019
TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patientsAnjali Joshi, Erin B Punke, Tugba Mehmetoglu-Gurbuz, et al.BMC Immunology|January 10, 2021
Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infectionHimanshu Garg, Rose Yeh, Douglas M Watts, et al.Cancers|November 27, 2021
Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular CarcinomaSheryl Rodriguez, Kristy Skeet, Tugba Mehmetoglu-Gurbuz, et al.Journal of Medicinal Chemistry|March 30, 2019
Anti-Zika Activity of a Library of Synthetic Carbohydrate ReceptorsKalanidhi Palanichamy, Anjali Joshi, Tugba Mehmetoglu-Gurbuz, et al.Pageof 2